Nuvenzepine
Nuvenzepine is an mAChR antagonist, has the potential for gastrospasm treatment.
Product Specifications
CAS Number
[96487-37-5]
UNSPSC
12352005
Target
MAChR
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
COVID-19-immunoregulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/Nuvenzepine.html
Purity
99.67
Solubility
10 mM in DMSO
Smiles
O=C1C2=CC=CN=C2N(C(C3CCN(C)CC3)=O)C4=CC=CC=C4N1
Molecular Formula
C19H20N4O2
Molecular Weight
336.39
References & Citations
[1]Barocelli E, et al. Functional comparison between nuvenzepine and pirenzepine on different guinea pig isolated smooth muscle preparations. Pharmacol Res. 1994 Aug-Sep;30 (2) :161-70.|[2]Barocelli E, et al. Gastrointestinal activities of a new pirenzepine-analog, nuvenzepine, in the cat. Farmaco. 1990 Oct;45 (10) :1089-99.|[3]Caselli G, et al. Determination of nuvenzepine in human plasma by a sensitive [3H]pirenzepine radioreceptor binding assay. J Pharm Sci. 1991 Feb;80 (2) :173-7.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
034207-PE 200 µL
CREB3L4, CT (CREB3L4, AIBZIP, CREB4, JAL, Cyclic AMP-responsive element-binding protein 3-like protein 4, Androgen-induced basic leucine zipper protein, Attaching to CRE-like 1, Cyclic AMP-responsive element-binding protein 4, Transcript induced in spermiogenesis protein 40, hJAL, Processed cyclic AMP-responsive element-binding protein 3-like protein 4) (PE) discontinued
Ask
View Details 
